Pathologists and clinical laboratory managers may want to learn more about the UCheck mobile app developed by Biosense Technologies
Developers of a new iPhone application claim their app can analyze a urine specimen for up to 25 different diseases. This mobile app is a deliberate attempt to give consumers the ability to perform diagnostic tests that would normally be run in a full-scale clinical laboratory.
Pathologists and clinical biochemists will want to visit the website of Biosense Technologies to check out this mobile application, which is called uCheck. Biosense is a medical device company located in Mumbai, India.
How A Cell Phone Can Be Used Like a Medical Laboratory Analyzer
Essentially, the uCheck app takes a picture of a urine sample and analyzes it for up to 25 diseases, noted an article published by BBC News. The test kit is priced at $20 and comes with five test sticks and a special mat. The test sticks are dipped into a urine sample and then placed on the mat. The iPhone takes a photo of the color-coded test sticks on the mat. The uChek application analyzes the image and interprets the results.
Biosense Technologies claims that uChek can detect as many as 10 parameters contained in the urine specimen, depending on the test strip used. This includes levels of:
Based on these parameters, the device could detect a range of conditions. These are listed as:
How the uChek App Works to Analyze a Urine Specimen
The uChek mobile application compares the results on the urine-soaked strips with a color-coded map. Using color comparisons as a guide, uChek analyzes the results and, within seconds, returns a breakdown of the different analytes it can detect. This was described in an article published by UPI.com.
uChek is the brainchild of entrepreneur Myshkin Ingawale, 29, a graduate of MIT. He is co-founder of Biosense Technologies and unveiled the app at a TED (Technology, Entertainment, Design) conference in February 2013. TED is a conference series that showcases “ideas worth spreading” that will shape the future.
Developer Wants Mobile Apps to Move Bio-chemistry into Mainstream
“There is huge potential to get the world of bio-chemistry out to users via apps,” declared Ingawale, who also invented ToucHB. This is a portable device that performs a blood test for anemia without breaking the patient’s skin. He designed this test device as a way to prevent women in developing countries from dying of anemia, by making it easy for healthcare workers—often untrained—to perform the required diagnostic tests in the field.
“I wanted to get medical health checks into users’ hands,” he told the BBC. “The idea is to get people closer to their own information. I want people to better understand what is going on in their bodies.
Substituting in the Field for the $10,000 Clinical Laboratory Instrument
If it does well, we can make it available to mobile clinics,” added Ingawale. “Instead of buying a $10,000 [clinical laboratory testing] machine, they can use their existing smartphones.”
To make this possible, Ingawale’s mobile phone app uses everyday language, such as “trace” or “large,” to describe results. The uCheck app also provides diagnostic information. For example, if users don’t know that presence of leukocytes could indicate a urinary tract infection, they can tap on the leukocytes tab to find the information, noted the UPI.com report.
uChek was tested at a Mumbai hospital on 1,200 urine samples. It did a better job than humans by just reading the color-coded strips. While sophisticated analyzers used in medical laboratories may be more accurate than uChek, they cost up to $10,000 and only read a specific type of test strip, noted Ingawale. “The medical device industry operates on a proprietary, closed hardware and a recurring revenue business model,” he said. “I’m trying to democratize healthcare.”
Biosense rolled out the Apple (NASDAQ: AAPL ) app in March 2013. The company is currently working on an Android version of the uChek mobile app.
Future of Wireless Medicine and Clinical Laboratory Tests
Ingawale consistently emphasizes that the idea isn’t to eliminate doctors or other professionals. In an interview published in The Atlantic, he further stated that his goal is to design a tool that helps people with chronic conditions—like diabetes or kidney, liver or bladder problems—better manage their disease.
However, Ingawale apparently would like his potentially disruptive technology to play a role in changing the in vitro diagnostics (IVD) industry. His statement that “the medical device industry operates on a proprietary, closed hardware and a recurring revenue business model” is consistent with his observations that a mobile app that uses a cell phone to accurately diagnose different diseases can democratize that aspect of healthcare—to the benefit of individuals, particularly in lesser-developed nations.
Thus, could it be that mobile applications designed to allow individuals to diagnose any number of medical conditions represent a threat to the IVD industry? Time will answer this question. But it is a question that strikes to the core of the existing business model for IVD manufacturers, which is to sell analyzers and reagents to large, centralized medical laboratories.